SCHEMBL6079288

SCHEMBL6079288

O=C(O)c1cc(CCc2ccccc2)c2cccc(O)c2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
KMT2A Q03164 1/20 0.48
SOX18 P35713 1/20 0.45
P2RX3 P56373 1/20 0.44
BID P55957 1/20 0.43
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
BAK1 Q16611 1/20 0.43
IGFBP3 P17936 2/20 0.41
IGFBP5 P24593 1/20 0.41
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CYP1A2 P05177 1/20 0.40
CCR6 P51684 1/20 0.40
PAX8 Q06710 1/20 0.40
HSD17B3 P37058 1/20 0.39
KDM4A O75164 1/20 0.39
RAB9A P51151 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6080007 0.87 KDM4E (0.45) KDM4ECYP1A2CCR6L3MBTL1
SCHEMBL6080124 0.85 PLAUR (0.45) KDM4EKMT2ASOX18P2RX3BID
SCHEMBL6597624 0.85 KDM4E (0.41) KDM4EP2RX3IGFBP5CSNK2A2CSNK2B
Hydrochloric Acid SCHEMBL6080175 0.84 KDM4E (0.40) KDM4EP2RX3IGFBP5CSNK2A2CSNK2B
SCHEMBL6080177 0.83 KDM4E (0.58) KDM4EKMT2AP2RX3PAX8KDM4A
SCHEMBL6080167 0.83 KDM4E (0.48) KDM4EKMT2ABIDBCL2L1MCL1
SCHEMBL6080099 0.82 KDM4E (0.47) KDM4EKMT2ABIDBCL2L1MCL1
SCHEMBL6604473 0.82 ALOX15 (0.54) KDM4EP2RX3IGFBP3IGFBP5CSNK2A2
Hydrochloric Acid SCHEMBL6080927 0.81 KDM4E (0.46) KDM4EKMT2ABIDBCL2L1MCL1
SCHEMBL6080368 0.81 KDM4E (0.46) KDM4EKMT2ABIDBCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060183909-A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof NEURO3D (FR) 2006-08-17 US claimed
US-20060183909-A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof NEURO3D (FR) 2006-08-17 US disclosed
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP disclosed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183909-A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof NQO1, NQO2, RECQL KDM4E 1006/4885KMT2A 1384/4885SOX18 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.